397 related articles for article (PubMed ID: 20638938)
1. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
2. Fbw7 repression by hes5 creates a feedback loop that modulates Notch-mediated intestinal and neural stem cell fate decisions.
Sancho R; Blake SM; Tendeng C; Clurman BE; Lewis J; Behrens A
PLoS Biol; 2013; 11(6):e1001586. PubMed ID: 23776410
[TBL] [Abstract][Full Text] [Related]
3. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
[TBL] [Abstract][Full Text] [Related]
4. The F-box protein Fbw7 is required for cerebellar development.
Jandke A; Da Costa C; Sancho R; Nye E; Spencer-Dene B; Behrens A
Dev Biol; 2011 Oct; 358(1):201-12. PubMed ID: 21827743
[TBL] [Abstract][Full Text] [Related]
5. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.
Fuchs SY
Cancer Biol Ther; 2005 May; 4(5):506-8. PubMed ID: 15908780
[TBL] [Abstract][Full Text] [Related]
7. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.
Hoeck JD; Jandke A; Blake SM; Nye E; Spencer-Dene B; Brandner S; Behrens A
Nat Neurosci; 2010 Nov; 13(11):1365-72. PubMed ID: 20935640
[TBL] [Abstract][Full Text] [Related]
8. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
10. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer.
Diefenbacher ME; Chakraborty A; Blake SM; Mitter R; Popov N; Eilers M; Behrens A
Cancer Res; 2015 Apr; 75(7):1181-6. PubMed ID: 25716680
[TBL] [Abstract][Full Text] [Related]
11. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
12. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
14. Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.
Thirimanne HN; Wu F; Janssens DH; Swanger J; Diab A; Feldman HM; Amezquita RA; Gottardo R; Paddison PJ; Henikoff S; Clurman BE
Elife; 2022 Feb; 11():. PubMed ID: 35225231
[TBL] [Abstract][Full Text] [Related]
15. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
[TBL] [Abstract][Full Text] [Related]
16. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
Tong J; Tan S; Zou F; Yu J; Zhang L
Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335
[TBL] [Abstract][Full Text] [Related]
17. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.
Welcker M; Clurman BE
Nat Rev Cancer; 2008 Feb; 8(2):83-93. PubMed ID: 18094723
[TBL] [Abstract][Full Text] [Related]
18. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
Galli F; Rossi M; D'Alessandra Y; De Simone M; Lopardo T; Haupt Y; Alsheich-Bartok O; Anzi S; Shaulian E; Calabrò V; La Mantia G; Guerrini L
J Cell Sci; 2010 Jul; 123(Pt 14):2423-33. PubMed ID: 20571051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
